Pollescas, Nilo B.
HRN: 21-95-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2022
CEFTRIAXONE 1G (VIAL)
10/14/2022
10/21/2022
2G
IV
Q24h
Small Bowel Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes